Bristol Myers Squibb today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Breyanzi® (lisocabtagene maraleucel; ...
Department of Retroperitoneal Tumor Surgery, Peking University International Hospital, Beijing, China ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback